Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Francisco Osvaldo García-Pérez"'
Autor:
Paola Vallejo-Armenta, Guillermina Ferro-Flores, Clara Santos-Cuevas, Francisco Osvaldo García-Pérez, Pamela Casanova-Triviño, Bayron Sandoval-Bonilla, Blanca Ocampo-García, Erika Azorín-Vega, Myrna Luna-Gutiérrez
Publikováno v:
Pharmaceuticals, Vol 15, Iss 6, p 729 (2022)
Fibroblast activation protein (FAP) is highly expressed on the cancer-associated fibroblasts (CAF) of the tumor stroma. Recently, we reported the preclinical evaluation and clinical biokinetics of a novel 99mTc-labeled FAP inhibitor radioligand ([99m
Externí odkaz:
https://doaj.org/article/f2ad2f7d31e9443ab8f57f8657701df3
Autor:
Joel Vargas Ahumada, Sofía D. González Rueda, Fabio A. Sinisterra Solís, Quetzali Pitalúa Cortés, Liliana P. Torres Agredo, Jimenez Ríos Miguel, Anna Scavuzzo, Irma Soldevilla-Gallardo, Miguel A. Álvarez Avitia, Nora Sobrevilla, Francisco Osvaldo García Pérez
Publikováno v:
Diagnostics, Vol 12, Iss 6, p 1387 (2022)
Neuroendocrine differentiation of prostate cancer (NEDPC) includes de novo presentation and secondary to epigenetic changes, referred as therapy-induced neuroendocrine prostate cancer (t-NEPC). Molecular imaging with prostate-specific membrane antige
Externí odkaz:
https://doaj.org/article/66162221b73742a58ef97a53d7399168
Autor:
Francisco Osvaldo, García-Pérez, Sevastian Salvador, Medina-Ornelas, Feliciano, Barron-Barron, Oscar, Arrieta-Rodriguez
Publikováno v:
American journal of nuclear medicine and molecular imaging. 10(3)
Human copper transporter 1 (hCtr1) is the main transporter of copper which has been involved as an essential cofactor in biological processes and mechanisms of action for cisplatin and its analogues. Although expression of hCtr1 is present in all tis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ba2ab54553af34400669d3a2ff017965
https://pubmed.ncbi.nlm.nih.gov/32704405
https://pubmed.ncbi.nlm.nih.gov/32704405
Autor:
Rocío Marlene Peruyero-Rivas, Francisco Osvaldo García-Pérez, Héctor Alva-Sánchez, Arnulfo Martínez-Dávalos, Mercedes Rodríguez-Villafuerte, Luis Fernando Torres-Urzúa
Publikováno v:
Physics in Medicine & Biology. 65:245003
A standard protocol for performance evaluation of positron emission mammography (PEM) systems has not yet been established. In this work we propose a methodology based on the design of specific phantoms for this imaging modality with component dimens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ffe1020b80a6dced9eb39483f6a41ce
https://doi.org/10.1088/1361-6560/aba7d1
https://doi.org/10.1088/1361-6560/aba7d1
Autor:
Francisco Osvaldo, García-Pérez, Jenny, Davanzo, Sergio, López-Buenrostro, Clara, Santos-Cuevas, Guillermina, Ferro-Flores, Miguel A, Jímenez-Ríos, Anna, Scavuzzo, Zael, Santana-Ríos, Sevastián, Medina-Ornelas
Publikováno v:
American journal of nuclear medicine and molecular imaging. 8(5)
Positron emission tomography (PET) with prostate-specific membrane antigen (PSMA) has found widespread use for the diagnosis of biochemical recurrence of prostate cancer (PCa). Unfortunately, PET/CT is not as widely available; thus a PSMA-targeting c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0108c3084e76f8ce326a8c5ae99fa86a
https://pubmed.ncbi.nlm.nih.gov/30510850
https://pubmed.ncbi.nlm.nih.gov/30510850
Autor:
Yolanda Villaseñor-Navarro, Irlanda Pacheco-Bravo, Juan Armando Reyes-Pérez, Guinevere Virginia López-Tecamachaltzi, Francisco Osvaldo García-Pérez, Roberto Alejandro Cruz-Morales, Carlos Martín Galindo-Sarco
Publikováno v:
Cervical Cancer ISBN: 9783319452302
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ac391e457d8f9a9af6a70a05e759520
https://doi.org/10.1007/978-3-319-45231-9_9
https://doi.org/10.1007/978-3-319-45231-9_9
Autor:
Quetzali Pitalua-Cortes, Francisco Osvaldo García-Perez, Joel Vargas-Ahumada, Sofia Gonzalez-Rueda, Edgar Gomez-Argumosa, Eleazar Ignacio-Alvarez, Irma Soldevilla-Gallardo, Liliana Torres-Agredo
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
IntroductionThyroid cancer is the main endocrine neoplasia worldwide, for which 131I therapy is the cornerstone treatment. One of the main problems of follow up in patients with this type of cancer, is the need for thyroglobulin stimulation, not to m
Externí odkaz:
https://doaj.org/article/97c57f3fa72f4161b36563366c5bab99